Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy

Por Iwasa, Satoru, Kudo, Toshihiro, Takahari, Daisuke, Hara, Hiroki, Kato, Ken, Satoh, Taroh
Publicado no Int J Clin Oncol (2020)

Correction to: Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapy

Por Iwasa, Satoru, Kudo, Toshihiro, Takahari, Daisuke, Hara, Hiroki, Kato, Ken, Satoh, Taroh
Publicado no Int J Clin Oncol (2020)

Do all patients in the phase I oncology trials need to be hospitalized? Domestic but outstanding issues for globalization of drug development in Japan

Por Shimomura, Akihiko, Kondo, Shunsuke, Kobayashi, Noriko, Iwasa, Satoru, Kitano, Shigehisa, Tamura, Kenji, Fujiwara, Yutaka, Yamamoto, Noboru
Publicado no Int J Clin Oncol (2017)

Phase 1 study of OCV‐C02, a peptide vaccine consisting of two peptide epitopes for refractory metastatic colorectal cancer

Por Taniguchi, Hiroya, Iwasa, Satoru, Yamazaki, Kentaro, Yoshino, Takayuki, Kiryu, Chika, Naka, Yoshiharu, Liew, Ei Leen, Sakata, Yuh
Publicado no Cancer Sci (2017)

Phase I study of alpelisib (BYL719), an α‐specific PI3K inhibitor, in Japanese patients with advanced solid tumors

Por Ando, Yuichi, Iwasa, Satoru, Takahashi, Shunji, Saka, Hideo, Kakizume, Tomoyuki, Natsume, Kazuto, Suenaga, Naoko, Quadt, Cornelia, Yamada, Yasuhide
Publicado no Cancer Sci (2019)

Phase I study of ipatasertib as a single agent and in combination with abiraterone plus prednisolone in Japanese patients with advanced solid tumors

Por Doi, Toshihiko, Fujiwara, Yutaka, Matsubara, Nobuaki, Tomomatsu, Junichi, Iwasa, Satoru, Tanaka, Akari, Endo-Tsukude, Chihiro, Nakagawa, Shintaro, Takahashi, Shunji
Publicado no Cancer Chemother Pharmacol (2019)

NC-6004 Phase I study in combination with gemcitabine for advanced solid tumors and population PK/PD analysis

Por Doi, Toshihiko, Hamaguchi, Tetsuya, Shitara, Kohei, Iwasa, Satoru, Shimada, Yasuhiro, Harada, Mitsunori, Naito, Kenichiro, Hayashi, Naoto, Masada, Atsuhiro, Ohtsu, Atsushi
Publicado no Cancer Chemother Pharmacol (2017)

A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metast...

Por Ohue, Masayuki, Iwasa, Satoru, Kanemitsu, Yukihide, Hamaguchi, Tetsuya, Shiozawa, Manabu, Ito, Masaaki, Yasui, Masayoshi, Katayama, Hiroshi, Mizusawa, Junki, Shimada, Yasuhiro
Publicado no Jpn J Clin Oncol (2017)

Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: A phase I study

Por Kato, Ken, Ura, Takashi, Koizumi, Wasaburo, Iwasa, Satoru, Katada, Chikatoshi, Azuma, Mizutomo, Ishikura, Satoshi, Nakao, Yoshinori, Onuma, Hiroshi, Muro, Kei
Publicado no Cancer Sci (2018)

Clinical impact of c-MET expression and genetic mutational status in colorectal cancer patients after liver resection

Por Shoji, Hirokazu, Yamada, Yasuhide, Taniguchi, Hirokazu, Nagashima, Kengo, Okita, Natsuko, Takashima, Atsuo, Honma, Yoshitaka, Iwasa, Satoru, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro
Publicado no Cancer Sci (2014)

Comprehensive screening of target molecules by next-generation sequencing in patients with malignant solid tumors: guiding entry into phase I clinical trials

Por Tanabe, Yuko, Ichikawa, Hitoshi, Kohno, Takashi, Yoshida, Hiroshi, Kubo, Takashi, Kato, Mamoru, Iwasa, Satoru, Ochiai, Atsushi, Yamamoto, Noboru, Fujiwara, Yasuhiro, Tamura, Kenji
Publicado no Mol Cancer (2016)

Esophageal Metastasis from Rectal Cancer Successfully Treated with Fluorouracil-Based Chemotherapy with Bevacizumab: A Case Report and Review of the Literature

Por Watanabe, Sho, Takashima, Atsuo, Taniguchi, Hirokazu, Tanaka, Yusaku, Nakamura, Shoko, Okita, Natsuko, Honma, Yoshitaka, Iwasa, Satoru, Kato, Ken, Hamaguchi, Tetsuya, Boku, Narikazu
Publicado no Case Rep Oncol (2017)

Case report: potential treatment of metastatic amphicrine carcinoma of the rectum with FOLFOXIRI chemotherapy

Por Tamura, Nobumasa, Honma, Yoshitaka, Sekine, Shigeki, Tsukamoto, Shunsuke, Hirano, Hidekazu, Okita, Natsuko, Shoji, Hirokazu, Iwasa, Satoru, Takashima, Atsuo, Kato, Ken, Boku, Narikazu
Publicado no Oxf Med Case Reports (2020)

Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer

Por Takahashi, Naoki, Yamada, Yasuhide, Taniguchi, Hirokazu, Fukahori, Masaru, Sasaki, Yusuke, Shoji, Hirokazu, Honma, Yoshitaka, Iwasa, Satoru, Takashima, Atsuo, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro
Publicado em 2014

Prognostic role of ERBB2, MET and VEGFA expression in metastatic colorectal cancer patients treated with anti-EGFR antibodies

Por Takahashi, Naoki, Iwasa, Satoru, Taniguchi, Hirokazu, Sasaki, Yusuke, Shoji, Hirokazu, Honma, Yoshitaka, Takashima, Atsuo, Okita, Natsuko, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro, Yamada, Yasuhide
Publicado no Br J Cancer (2016)

Safety, tolerability and pharmacokinetics of the fibroblast growth factor receptor inhibitor AZD4547 in Japanese patients with advanced solid tumours: a Phase I study

Por Saka, Hideo, Kitagawa, Chiyoe, Kogure, Yoshihito, Takahashi, Yasuo, Fujikawa, Koshi, Sagawa, Tamotsu, Iwasa, Satoru, Takahashi, Naoki, Fukao, Taro, Tchinou, Catherine, Landers, Dónal, Yamada, Yasuhide
Publicado no Invest New Drugs (2017)

First‐in‐human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors

Por Koyama, Takafumi, Shimizu, Toshio, Iwasa, Satoru, Fujiwara, Yutaka, Kondo, Shunsuke, Kitano, Shigehisa, Yonemori, Kan, Shimomura, Akihiko, Iizumi, Sakura, Sasaki, Tatsuya, Furuse, Junji, Yamamoto, Noboru
Publicado no Cancer Sci (2020)

Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study

Por Arai, Hiroyuki, Iwasa, Satoru, Boku, Narikazu, Kawahira, Masahiro, Yasui, Hirofumi, Masuishi, Toshiki, Muro, Kei, Minashi, Keiko, Hironaka, Shuichi, Fukuda, Naoki, Takahari, Daisuke, Nakajima, Takako Eguchi
Publicado no BMC Cancer (2019)

Serum level of hepatocyte growth factor is a novel marker of predicting the outcome and resistance to the treatment with trastuzumab in HER2-positive patients with metastatic gastr...

Por Takahashi, Naoki, Furuta, Koh, Taniguchi, Hirokazu, Sasaki, Yusuke, Shoji, Hirokazu, Honma, Yoshitaka, Iwasa, Satoru, Okita, Natsuko, Takashima, Atsuo, Kato, Ken, Hamaguchi, Tetsuya, Shimada, Yasuhiro, Yamada, Yasuhide
Publicado no Oncotarget (2015)

Imaging peritoneal metastasis of gastric cancer with (18)F-fluorothymidine positron emission tomography/computed tomography: a proof-of-concept study

Por Honma, Yoshitaka, Terauchi, Takashi, Tateishi, Ukihide, Kano, Daisuke, Nagashima, Kengo, Shoji, Hirokazu, Iwasa, Satoru, Takashima, Atsuo, Kato, Ken, Hamaguchi, Tetsuya, Boku, Narikazu, Shimada, Yasuhiro, Yamada, Yasuhide
Publicado no Br J Radiol (2018)